Cansino Biologics Inc. focuses on the R&D, production and commercialization of human vaccines. The company provides adenovirus vector vaccine technology, protein structure design and recombination technology, binding technology and preparation technology etc. The company was founded in 2009, headquartered in Tianjin City, China.
Headquarters
Biomedical Park, West District, No. 185, South Street, West District, Economic and Technological Development Zone, Dongli District, Tianjin
Tianjin; Tianjin;
Postal Code: 300457
Contact Details: Purchase the Cansino Biologics Inc. report to view the information.
Website: http://www.cansinotech.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service